INSIGHTS ON DRUG DEVELOPMENT
-
How AI Is Reshaping Pharmacovigilance: Key Takeaways From The New CIOMS Report
Deploying AI in pharmacovigilance requires risk-based oversight, human accountability, transparent governance, and representative performance testing.
-
Don't Intensify Blindly: Preventing Fouling And Restoring Performance With Targeted Cleaning Of Protein A Resins
Protein A chromatography intensification can increase productivity, but it may also affect process robustness. Explore key tradeoffs, operational challenges, and practical considerations.
-
Producing Quality APIs At Scale
Targeted process optimization transformed an early‑phase API with yield and impurity challenges into a scalable, high‑quality manufacturing process ready to support ongoing drug development.
-
Alzheimer's Disease Pathway
Alzheimer’s disease (AD) affects 50 million people globally, causing cognitive decline. Explore the signaling pathways of amyloid beta and tau proteins, linking them to neuronal death and AD symptoms.
-
Biophysical Tools For Biotherapeutic Development6/26/2025
Discover essential analytical techniques in biotherapeutics development, as well as explore ITC, DSC, and Rheology—powerful tools for understanding formulation, stability, and efficacy in drug development.
-
Solvent Recovery Systems For Sustainable Pharma Manufacturing10/9/2026
Solvent recovery can reduce waste, but scaling it brings technical and regulatory risks. See how three approaches performed and what it takes to move from bench to commercial scale.
-
From Model To Molecule: Combining AI And Experimental Strategies To Transform Drug Development3/8/2026
See how integrating AI-driven predictive modeling with well-designed experimental validation can help overcome development challenges, improve decision-making, and support accurate evaluation of API solid-state properties.
-
Spray Dried Biologics For Pulmonary Dosage Forms5/8/2026
View how spray drying enables stable, precisely engineered pulmonary powders for biologics, supporting efficient lung delivery, scalability, and preservation of molecular structure and activity.
-
Episodic Vs. Continuous Readiness: Which Operating Model Is Carrying Your Biotech Forward?5/11/2026
Transitioning from episodic audit prep to continuous readiness protects clinical timelines. Evaluate your quality operating model to support scalable growth today.
DRUG DEVELOPMENT SOLUTIONS
-
Measure heat flow, weight loss, dimension change, or mechanical properties as a function of temperature.
-
Next-generation fluorescent imaging solution for the assurance of monoclonality and automated confluence across diverse cell types
Demonstrating that cell lines are monoclonal – or that a gene was edited as expected – can be a time-consuming and highly-subjective process when relying on conventional technologies. The CloneSelect® Imager and CloneSelect® Imager FL are a high-throughput automated solutions for imaging and analyzing mammalian cells. Tracking the formation of a colony from a single cell is effortless as barcoded plates are tracked over time. Automated acquisition and analysis provides accurate, objective, and consistent results.
-
Early identification of potential absorption risks is critical for rapid and efficient drug development. Lonza's PBPK modeling services are designed to de-risk your drug development program.
-
Outsourcing can accelerate development by reducing operational complexity while providing access to expert partners, advanced technologies, and scalable manufacturing.
-
Observe how comprehensive R&D support advances therapeutic oligonucleotides from discovery through commercialization with tailored formulation development services across multiple modalities and delivery platforms.